Yemaachi Biotechnology
PrivateLast Round
Grant
Mar 6, 2024
Est. Valuation
$1.79M
Total Funding Raised
$4.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Yemaachi Biotechnology is a precision oncology company that leverages African genomic diversity to develop next-generation cancer diagnostics and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yemaachi Biotechnology Comparables
Compare Yemaachi Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syndicate Bio | 78% | |
| MyAfroDNA | 78% | |
| Pahtia Technologies | 73% |
Yemaachi Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2024 | ||||
| Seed | Mar 21, 2022 | ||||
| Grant | Oct 20, 2021 | ||||
| Accelerator | Aug 9, 2021 |
Yemaachi Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Cancer Grand Challenges | Grant |
| LifeLine Financial Group | Seed |
| LoftyInc Capital Management | Seed |
| Cancer Research UK | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Y Combinator | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 58% MoM.
- Oct 30, 2025
Collaborating with Bio Usawa Inc. on drug development and manufacturing.
Yemaachi Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yemaachi Biotechnology's valuation, stock price, and market status.
Is Yemaachi Biotechnology a public or private company?
Yemaachi Biotechnology is a private company.
What is the current stock price of Yemaachi Biotechnology?
Yemaachi Biotechnology is a private company, so its shares have no public market price. Caplight tracks Yemaachi Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yemaachi Biotechnology worth (valuation)?
Yemaachi Biotechnology's valuation is estimated at $1.8M based on funding round data.
Can I buy Yemaachi Biotechnology stock?
Yemaachi Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yemaachi Biotechnology's last funding round?
Yemaachi Biotechnology's most recent funding round was Grant on March 6, 2024.
Who are the main investors in Yemaachi Biotechnology?
Key investors in Yemaachi Biotechnology include V8 Capital Partners.
Will Yemaachi Biotechnology IPO soon?
No public IPO plans have been announced for Yemaachi Biotechnology.
How can I track Yemaachi Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Yemaachi Biotechnology's shares on secondary markets.